PlainRecalls
FDA Drug Low Class III Terminated

Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30

Reported: August 6, 2014 Initiated: June 19, 2014 #D-1485-2014

Product Description

Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30

Reason for Recall

Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.

Details

Recalling Firm
Pfizer Inc.
Units Affected
22,461 bottles
Distribution
Nationwide (Continental USA and Puerto Rico). A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market. One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope. Only the product distributed within US/PR market (bottles) is in the scope of this recall.
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30. Recalled by Pfizer Inc.. Units affected: 22,461 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 6, 2014. Severity: Low. Recall number: D-1485-2014.